Understanding the signaling cross-talk between miR-489 and HER2 indicate that the HER2-SHP2-MAPK signaling axis and miR-489 form a double-negative regulation loop to regulate cell proliferation in breast cancer (Figure 4F). Here, ERBB2 is linked to breast carcinoma.